Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
Open Access
- 12 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 902143
Abstract
Glioma is a highly malignant brain tumor with a poor survival rate. The involvement of fatty acid metabolism in glioma was examined to find viable treatment options. The information was gathered from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases. A prognostic signature containing fatty acid metabolism-dependent genes (FAMDs) was developed to predict glioma outcome by multivariate and most minor absolute shrinkage and selection operator (LASSO) regression analyses. In the TCGA cohort, individuals with a good score had a worse prognosis than those with a poor score, validated in the CGGA cohort. According to further research by “pRRophetic” R package, higher-risk individuals were more susceptible to crizotinib. According to a complete study of the connection between the predictive risk rating model and tumor microenvironment (TME) features, high-risk individuals were eligible for activating the immune cell-associated receptor pathway. We also discovered that anti-PD-1/PD-L1 and anti-CTLA4 immunotherapy are more effective in high-risk individuals. Furthermore, we demonstrated that CCNA2 promotes glioma proliferation, migration, and invasion and regulates macrophage polarization. Therefore, examining the fatty acid metabolism pathway aids our understanding of TME invasion properties, allowing us to develop more effective immunotherapies for glioma.Keywords
Funding Information
- National Natural Science Foundation of China (81873248, 81673903)
This publication has 41 references indexed in Scilit:
- Lipid metabolism reprogramming and its potential targets in cancerCancer Communications, 2018
- 2016 World Health Organization Classification of Central Nervous System TumorsContinuum, 2017
- Crizotinib targets in glioblastoma stem cellsCancer Medicine, 2017
- Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancerCancer Letters, 2017
- Imaging metabolic heterogeneity in cancerMolecular Cancer, 2016
- mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunityScience, 2014
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Molecular pathogenesis of malignant gliomasCurrent Opinion in Oncology, 1999
- Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells.Journal of Biological Chemistry, 1994
- Use of a new stapling instrument for permanent occlusion of the aorta in the surgical procedure for thromboexclusionThe Annals of Thoracic Surgery, 1989